RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1171
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CSP)
Details mutation: the H-2K(d) epitope SYIPSAEKI mutated to SIINFEKL, an H-2K(b) epitope and deletion of N-terminus
Phenotype Sporozoite; Liver stage;
Last modified: 18 February 2015, 19:38
  *RMgm-1171
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25658939
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherA.J. Radtke; I.A. Cockburn; F. Zavala
Name Group/DepartmentJohns Hopkins Malaria Research Institute and Department of Molecular Microbiology and Immunology
Name InstituteJohns Hopkins Bloomberg School of Public Health, Johns Hopkins University
CityBaltimore
CountryUSA
Name of the mutant parasite
RMgm numberRMgm-1171
Principal nameCS5MΔN
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteSee RMgm-609 for analyses of mutant sporozoites that lack the entire N terminus excluding the signal sequence (including region I). Salivary gland sporozoites are produced but after intradermal inoculation into mice, most sporozoites did not reach the liver but were trapped in the skin. After intravenous infection they show a normal/higher infectivity.
Liver stageSee RMgm-609 for analyses of mutant sporozoites that lack the entire N terminus excluding the signal sequence (including region I). Salivary gland sporozoites are produced but after intradermal inoculation into mice, most sporozoites did not reach the liver but were trapped in the skin. After intravenous infection they show a normal/higher infectivity.
Additional remarks phenotype

Mutant/mutation
In the mutant (CS5MΔN) the wild type cs gene is replaced with a mutated cs gene carrying 5 mutations that changed the natural H-2Kd restricted epitope SYIPSAEKI to SIINFEKL, an H-2Kb restricted epitope and the mutated cs gene lacks the entire N terminus excluding the signal sequence (including region I).

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
See additional information below

Additional information
From the paper:
'As a second approach, we generated mutant parasites that expressed the SIINFEKL epitope in a CS-restricted manner and were unable to migrate out of the skin due to a deletion in the N-terminal third of the CS protein (RMgm-609], P. berghei CS5MΔN. In further agreement with the hypothesis that sporozoite motility is required for parasite entry into the lymphatics, P. berghei CS5MΔN sporozoites exhibited a severe impairment in their migration to the DLN. To evaluate the effect of these changes in DLN access on the development of cell-mediated immunity, mice were given CFSE-labeled OT-1 cells, injected ID with P. berghei CS5M (RMgm-609] or P. berghei CS5MΔN sporozoites, and OT-1 proliferation was examined 3 days later in the DLN. OT-1 proliferation was significantly reduced in mice injected with P. berghei CS5MΔN sporozoites. To determine whether the diminished CD8+ T cell response observed at day 3 was due to a delay in sporozoite migration to the DLN, rather than an absolute reduction, we measured the expansion of OT-1 cells in the DLN, spleen, and liver 10 days after ID inoculation of P. berghei CS5M or P. berghei CS5MΔN sporozoites. In line with our previous findings, we found that ID immunization with P. berghei CS5MΔN sporozoites led to drastically reduced OT-1 responses 10 days after immunization as compared to P. berghei CS5M sporozoites. Importantly, when injected IV, P. berghei CS5MΔN sporozoites were fully infectious and induced similar OT-1 responses in the spleen and liver as compared to control parasites (P. berghei CS5M). These findings demonstrate that the SIINFEKL epitope is expressed by the mutant parasite and is efficiently presented by APCs upon sporozoite access to lymphoid organs. Together, our studies with Fab-treated and transgenic parasites establish a critical role for sporozoite migration to the DLN in CD8+ T cell priming after ID inoculation.

Other mutants
RMgm-613: A mutant with the wild type cs gene replaced with a mutated cs gene carrying 5 mutations that changed the natural H-2Kd restricted epitope SYIPSAEKI to SIINFEKL, an H-2Kb restricted epitope

RMgm-609: A mutant with the wild type csp replaced with a mutated csp containing a specific deletion of entire N terminus, (including region I) and  excluding the signal sequence (amino acids NKSIQAQRNLNELCYNEGNDNKLYHVLNSKNGKIYNRNTVNRLLADAPEGKKNEKKNEKIERNNKLKQP)


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCSP
Details of the genetic modification
Short description of the mutationthe H-2K(d) epitope SYIPSAEKI mutated to SIINFEKL, an H-2K(b) epitope and deletion of N-terminus
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid KpnI, SacI
Selectable marker used to select the mutant parasitepbdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationP. berghei CS5MΔN parasites were created by transfection of P. berghei ANKA with a linearized pR-CSRepΔN5M plasmid. The pR-CSRepΔN5M plasmid was generated by ligating an EagI-PacI digestion product of the pCSRep5M plasmid into the pR-CSRepΔN plasmid containing the N-terminal deletion of the CSP locus and a drug selection cassette. See also RMgm-609 and RMgm-613.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6